TIAA FSB’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $1.04M | Sell |
14,601
-406
| -3% | -$29.1K | ﹤0.01% | 311 |
|
|
2023
Q1 | $1.04M | Buy |
15,007
+257
| +2% | +$17.8K | ﹤0.01% | 312 |
|
|
2022
Q4 | $1M | Sell |
14,750
-416
| -3% | -$28.2K | ﹤0.01% | 309 |
|
|
2022
Q3 | $832K | Sell |
15,166
-1,348
| -8% | -$74K | ﹤0.01% | 331 |
|
|
2022
Q2 | $1.09M | Sell |
16,514
-2,231
| -12% | -$147K | ﹤0.01% | 311 |
|
|
2022
Q1 | $1.03M | Sell |
18,745
-5,029
| -21% | -$277K | ﹤0.01% | 308 |
|
|
2021
Q4 | $1.19M | Sell |
23,774
-1,416
| -6% | -$70.9K | ﹤0.01% | 297 |
|
|
2021
Q3 | $1.51M | Buy |
25,190
+3,470
| +16% | +$208K | 0.01% | 283 |
|
|
2021
Q2 | $1.3M | Sell |
21,720
-755
| -3% | -$45.2K | ﹤0.01% | 297 |
|
|
2021
Q1 | $1.12M | Sell |
22,475
-5,142
| -19% | -$256K | ﹤0.01% | 297 |
|
|
2020
Q4 | $1.38M | Sell |
27,617
-2,106
| -7% | -$105K | 0.01% | 272 |
|
|
2020
Q3 | $1.63M | Sell |
29,723
-5,046
| -15% | -$277K | 0.01% | 230 |
|
|
2020
Q2 | $1.84M | Buy |
34,769
+12,917
| +59% | +$683K | 0.01% | 225 |
|
|
2020
Q1 | $977K | Sell |
21,852
-1,580
| -7% | -$70.6K | 0.01% | 229 |
|
|
2019
Q4 | $1.17M | Sell |
23,432
-5,652
| -19% | -$282K | 0.01% | 254 |
|
|
2019
Q3 | $1.3M | Sell |
29,084
-2,677
| -8% | -$119K | 0.01% | 241 |
|
|
2019
Q2 | $1.31M | Sell |
31,761
-429
| -1% | -$17.7K | 0.01% | 234 |
|
|
2019
Q1 | $1.3M | Sell |
32,190
-267,789
| -89% | -$10.8M | 0.01% | 241 |
|
|
2018
Q4 | $11.4M | Sell |
299,979
-70,969
| -19% | -$2.7M | 0.06% | 97 |
|
|
2018
Q3 | $14.7M | Sell |
370,948
-30,488
| -8% | -$1.21M | 0.08% | 89 |
|
|
2018
Q2 | $14.1M | Buy |
401,436
+147,433
| +58% | +$5.18M | 0.08% | 86 |
|
|
2018
Q1 | $8.88M | Buy |
254,003
+226,916
| +838% | +$7.93M | 0.05% | 112 |
|
|
2017
Q4 | $940K | Buy |
27,087
+1,692
| +7% | +$58.7K | 0.01% | 315 |
|
|
2017
Q3 | $860K | Buy |
25,395
+2,891
| +13% | +$97.9K | 0.01% | 323 |
|
|
2017
Q2 | $767K | Buy |
+22,504
| New | +$767K | 0.01% | 319 |
|